摘要
目的观察布地奈德吸入辅助治疗急性会厌炎的临床疗效。方法选取我院自2006年1月～2008年12月收治的106例急性会厌炎患者随机分为观察组(布地奈德辅助治疗组)和对照组(常规治疗组)各53例,观察比较两组的治疗效果。结果 (1)观察组痊愈26例,显效19例,有效8例,总有效率为84.9%;对照组痊愈11例,显效21例,有效20例,总有效率为60.4%。两组比较差异显著(P<0.01),具有统计学意义;(2)观察组无一例建立人工气道,对照组建立人工气道6例,两组比较差异明显(P<0.05),具有统计学意义。结论布地奈德吸入辅助治疗急性会厌炎可以提高临床治疗效果,缩短治疗时间,减少窒息引发危险。
Objective To observe the adjuvant treatment of budesonide inhalation of the clinical effect of acute epiglottitis. Methods In our hospital from January 2006-December 2008 106 cases were admitted with acute epiglottitis were randomly divided into two groups （budesonide adjuvant therapy group） and control group （conventional treatment group） of the 53 cases observed and compared two groups of treatment. Results （1） Observation of 26 cases were cured, 19 cases were markedly effective in 8 cases, total effective rate was 84.9%; control group healed in 11 cases, 21 cases markedly effective in 20 cases, total effective rate was 60.4%. Significant difference between the two groups （P0.01）, with statistical significance; （2） The observation group, two patients with the artificial airway in the control group 6 cases of the artificial airway, the difference being significant （P0.05）, statistically significance. Conclusion Budesonide Inhalation Acute epiglottitis can improve clinical outcomes, shorten treatment time, reduce the risk of suffocation caused.
出处
《当代医学》
2010年第28期133-134,共2页
Contemporary Medicine
